Immuron Limited (ASX:IMC)
Australia · Delayed Price · Currency is AUD 0.0420
+0.0050 (13.51%)
Aug 26, 2026, 3:02 PM AEST
Immuron Market Cap
Immuron has a market cap or net worth of 12.09 million as of August 26, 2026. Its market cap has decreased by -37.42% in one year.
Market Cap
12.09M
Enterprise Value
2.29M
Revenue
7.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
ChartMarket Cap Chart
Since September 14, 1999, Immuron's market cap has decreased from 37.31M to 12.09M, a decrease of -67.60%. That is a compound annual growth rate of -4.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 12.09M | 3.14% |
| Dec 31, 2025 | 11.72M | -35.27% |
| Dec 30, 2024 | 18.10M | 3.20% |
| Dec 29, 2023 | 17.54M | -10.47% |
| Dec 30, 2022 | 19.59M | -14.00% |
| Dec 31, 2021 | 22.78M | -56.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EZZ Life Science Holdings | 24.48M |
| Algorae Pharmaceuticals | 22.28M |
| Patrys | 20.67M |
| Neurotech International | 15.81M |
| Ceryvyn Therapeutics | 15.05M |
| ReNerve | 13.27M |
| Cambium Bio | 12.36M |
| AdAlta | 11.24M |